These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25946103)
1. CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2. Wojta-Stremayr D; Neunkirchner A; Srinivasan B; Trapin D; Schmetterer KG; Pickl WF PLoS One; 2015; 10(5):e0126034. PubMed ID: 25946103 [TBL] [Abstract][Full Text] [Related]
2. IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation. Boulet S; Daudelin JF; Labrecque N J Immunol; 2014 Aug; 193(4):1847-54. PubMed ID: 25015830 [TBL] [Abstract][Full Text] [Related]
3. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. Kueng HJ; Leb VM; Haiderer D; Raposo G; Thery C; Derdak SV; Schmetterer KG; Neunkirchner A; Sillaber C; Seed B; Pickl WF J Virol; 2007 Aug; 81(16):8666-76. PubMed ID: 17537846 [TBL] [Abstract][Full Text] [Related]
4. Naive CD8+ T cells differentiate into protective memory-like cells after IL-2 anti IL-2 complex treatment in vivo. Kamimura D; Bevan MJ J Exp Med; 2007 Aug; 204(8):1803-12. PubMed ID: 17664293 [TBL] [Abstract][Full Text] [Related]
6. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. Jackson RJ; Worley M; Trivedi S; Ranasinghe C Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs. Hauser C; Zipprich F; Leblond I; Wirth S; Hügin AW J Immunol; 1999 Jul; 163(1):330-6. PubMed ID: 10384132 [TBL] [Abstract][Full Text] [Related]
8. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes. Kim S; Shen T; Min B J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092 [TBL] [Abstract][Full Text] [Related]
9. Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules. Derdak SV; Kueng HJ; Leb VM; Neunkirchner A; Schmetterer KG; Bielek E; Majdic O; Knapp W; Seed B; Pickl WF Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13144-9. PubMed ID: 16924110 [TBL] [Abstract][Full Text] [Related]
10. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation. Sepulveda H; Cerwenka A; Morgan T; Dutton RW J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007 [TBL] [Abstract][Full Text] [Related]
11. BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes. Manders PM; Hunter PJ; Telaranta AI; Carr JM; Marshall JL; Carrasco M; Murakami Y; Palmowski MJ; Cerundolo V; Kaech SM; Ahmed R; Fearon DT Proc Natl Acad Sci U S A; 2005 May; 102(21):7418-25. PubMed ID: 15833813 [TBL] [Abstract][Full Text] [Related]
12. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474 [TBL] [Abstract][Full Text] [Related]
13. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells. Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662 [TBL] [Abstract][Full Text] [Related]
14. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells. Kos FJ; Müllbacher A Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266 [TBL] [Abstract][Full Text] [Related]
15. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805 [TBL] [Abstract][Full Text] [Related]
16. Differential outcome of IL-2/anti-IL-2 complex therapy on effector and memory CD8+ T cells following vaccination with an adenoviral vector encoding EBV epitopes. Smith C; Martinez M; Peet J; Khanna R J Immunol; 2011 May; 186(10):5784-90. PubMed ID: 21482735 [TBL] [Abstract][Full Text] [Related]
17. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice. Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311 [TBL] [Abstract][Full Text] [Related]
18. Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T cells in vivo. D'Souza WN; Lefrançois L Eur J Immunol; 2004 Nov; 34(11):2977-85. PubMed ID: 15384078 [TBL] [Abstract][Full Text] [Related]
19. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro. Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027 [TBL] [Abstract][Full Text] [Related]
20. IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditions. Le Saout C; Villard M; Cabasse C; Jacquet C; Taylor N; Hernandez J PLoS One; 2010 Sep; 5(9):e12659. PubMed ID: 20856822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]